4426
W.A.E. Omar, O.E.O. Hormi / Tetrahedron 65 (2009) 4422–4428
181–182 ꢂC; IR (KBr):
n
1172, 1340, 1504, 2220, 2925, 3331 cmꢁ1. 1H
amounts of chemicals used to prepare the title compound. Aceto-
NMR (200 MHz, DMSO-d6):
d
2.35 (s, 3H), 7.36–7.40 (d, J¼7.5 Hz, 2H),
ne/n-hexane mixture (3:2) was used as eluent to purify the product
by flash chromatography, which was obtained as a white powder
(78.9 mg, 37%). Using PdCl2 (10 mol %) and PPh3 (20 mol %)
under same reaction condition afforded the title compound 3g
7.47–7.50 (d, J¼8.1 Hz, 1H), 7.57–7.65 (m, 2H), 7.77–7.88 (m, 5H),
7.96–8.00 (m, 2H), 8.16 (d, J¼16.2 Hz,1H), 8.46–8.50 (d, J¼9.2 Hz,1H),
8.78–8.80 (d, J¼4.8 Hz, 1H). 13C NMR (50 MHz, DMSO-d6):
d 21.96,
111.56, 118.69, 119.71, 122.91, 124.57, 126.58, 126.97, 128.06, 129.08,
129.18 (3C), 130.68 (2C), 133.22, 133.48 (2C), 134.83, 141.68, 142.37,
142.54,145.91,146.24,151.43. HRMS (MþH)þ calcd for C25H19N2O3S:
427.1116, found: 427.1111.
(209.1 mg, 98%). Mp: 160–161 ꢂC; IR (KBr):
n 1177, 1348, 1588,
2.36 (s, 3H), 7.37–7.41
3045 cmꢁ1. 1H NMR (200 MHz, DMSO-d6):
d
(d, J¼8.1 Hz, 2H), 7.49–7.88 (m, 8H), 8.25–8.33 (d, J¼15.2 Hz, 1H),
8.47–8.51 (d, J¼8.1 Hz,1H), 8.60–8.63 (d, J¼5.5 Hz, 2H), 8.80–8.82 (d,
J¼5.2 Hz, 1H). 13C NMR (50 MHz, DMSO-d6):
d 22.06, 118.94, 122.53,
4.3.4. (E)-4-(4-Methylstyryl)-8-tosyloxyquinoline (3d)
122.55, 124.56, 127.07, 127.59, 128.03, 129.20 (3C), 130.69 (2C),
133.22,134.14,142.37 (2C),144.15,145.93,146.27,151.01 (2C),151.56.
HRMS (MþH)þ calcd for C23H19N2O3S: 403.1116, found: 403.1104.
4-Bromo-8-tosyloxyquinoline 2 (200 mg, 0.53 mmol), PdCl2
(2.82 mg, 0.016 mmol), PPh3 (8.35 mg, 0.03 mmol), K2CO3
(73.32 mg, 0.53 mmol) and 0.14 mL of 4-methylstyrene were used
to prepare the title compound. The product was purified using
acetone/n-hexane (1:2) as eluent giving (147 mg, 67%) as white
4.3.8. (E)-4-(2-(Pyridin-2-yl)vinyl)-8-tosyloxyquinoline (3h)
4-Bromo-8-tosyloxyquinoline 2 (200 mg, 0.53 mmol), PdCl2
(2.82 mg, 0.016 mmol), PPh3 (8.35 mg, 0.03 mmol), K2CO3
(73.32 mg, 0.53 mmol) and 0.11 mL 2-vinylpyridine were used to
prepare the title compound. The product was purified using ace-
tone/n-hexane (1:2) as eluent in flash chromatography giving the
title compound as a white powder (42.7 mg, 20%). Using PdCl2
(10 mol %) and PPh3 (20 mol %) under same previous conditions
solid. Mp: 184–185 ꢂC; IR (KBr):
n
1177, 1376, 1585, 1630, 3037 cmꢁ1
2.36 (s, 3H), 2.40 (s, 3H), 7.25–7.29
.
1H NMR (200 MHz, DMSO-d6):
d
(d, J¼8.3 Hz, 2H), 7.41–7.45 (d, J¼8.6 Hz, 2H), 7.51–7.65 (m, 3H),
7.69–7.76 (m, 2H), 7.82–7.89 (m, 3H), 7.97–8.05 (d, J¼16.2, 1H),
8.49–8.53 (d, J¼8.3 Hz, 2H), 8.78–8.80 (d, J¼5.1 Hz, 1H). HRMS
(MþH)þ calcd for C25H22NO3S: 416.1320, found: 416.1316.
increased the yield to 192 mg, 90%. Mp: 127–128 ꢂC; IR (KBr):
n
1180, 1377, 1584, 3042 cmꢁ1. 1H NMR (200 MHz, DMSO-d6):
d
2.36
4.3.5. (E)-4-(4-Chlorostyryl)-8-tosyloxyquinoline (3e)
(s, 3H), 7.34–7.90 (m, 11H), 8.31–8.41 (m, 2H), 8.64–8.66 (d,
4-Bromo-8-tosyloxyquinoline 2 (200 mg, 0.53 mmol), PdCl2
(2.82 mg, 0.016 mmol), PPh3 (8.35 mg, 0.03 mmol), K2CO3
(73.32 mg, 0.53 mmol) and 0.13 mL of 4-chlorostyrene were used to
prepare the title compound. The product was purified by flash
chromatography using acetone/n-hexane (1:2) as eluent affording
J¼4.1 Hz, 1H), 8.80–8.83 (d, J¼4.6 Hz, 1H). 13C NMR (50 MHz,
DMSO-d6):
d 21.96, 118.9, 122.87, 124.10, 124.30, 124.35, 126.16,
127.16,128.09 (2C),129.20 (2C),130.69,133.24,136.08,137.9,142.35,
142.41, 146.00, 146.25, 150.61, 151.50, 154.86. HRMS (MþH)þ calcd
for C23H19N2O3S: 403.1116, found: 403.1131.
(161.6 mg, 70%) as a white powder. Mp: 144–145 ꢂC; IR (KBr):
1178, 1373, 1586, 1626, 3038 cmꢁ1. 1H NMR (200 MHz, DMSO-d6):
2.40 (s, 3H), 7.40–7.45 (d, J¼8.3 Hz, 2H), 7.50–7.65 (m, 5H), 7.82–
n
4.4. General procedure for synthesis of 4-(2-arylvinyl)-8-
hydroxyquinoline (4a, 4b and 4d–h)
d
7.90 (m, 5H), 8.06–8.14 (d, J¼16.2, 1H), 8.50–8.54 (d, J¼8.3 Hz, 1H),
8.81–8.83 (d, J¼4.7 Hz, 1H). 13C NMR (50 MHz, DMSO-d6):
d 22.02,
4-(2-Arylvinyl)-8-tosyloxyquinolines 3a,b and d–h were dis-
solved in ethanol (25 mL) and NaOH (1 M, 5 equiv) was then added.
The mixture was refluxed for 1 h, then more water was added and
the mixture was neutralized with HCl (1 M). The precipitate formed
was filtered, washed with water and dried in an oven at 50 ꢂC for
3 h.
118.32, 123.00, 123.69, 125.00, 126.85, 128.14, 129.23 (2C), 129.67
(2C), 130.18 (2C), 130.72 (2C), 133.30, 134.20, 135.29, 136.12, 142.43,
143.04, 145.96, 146.28, 151.44. HRMS (MþH)þ calcd for
C24H19NO3SCl: 436.0774, found: 436.0774.
4.3.6. (E)-4-(2,4,6-Trimethoxystyryl)-8-tosyloxyquinoline (3f)
The following amounts of chemicals were used to prepare the title
compound: 4-bromo-8-tosyloxyquinoline 2 (200 mg, 0.53 mmol),
PdCl2 (2.82 mg, 0.016 mmol), PPh3 (8.35 mg, 0.03 mmol), K2CO3
(73.32 mg, 0.53 mmol) and 0.14 mL of 2,4,6-trimethoxystyrene,44
which was prepared in 98% yield as yellowish oil by stirring meth-
yltriphenylphosphonium bromide (1.365 g, 3.8 mmol) and NaH
(0.15 g, 3.75 mmol) in THF for 2 h at room temperature followed by
the addition of 2,4,6-trimethoxybenzaldehyde (0.5 g, 2.5 mmol),
reflux for 2 h and flash chromatography using an acetone and n-
hexane mixture (1:2). The title compound 3f was purified by flash
chromatography using EtOAc/n-hexane (1:2) as eluent affording
(224.1 mg, 86%) of 3f as bright yellow powder. Mp: 133–134 ꢂC; IR
4.4.1. (E)-4-Styrylquinolin-8-ol (4a)
4-Styryl-8-tosyloxyquinoline 3a (0.5 g, 1.25 mmol) and NaOH
(1 M, 6.23 mL, 6.23 mmol) were used to prepare the title com-
pound. The product was collected and recrystallized from
a CHCl3/EtOH mixture giving a reddish powder (0.3 g, 99%). Mp:
180–181 ꢂC; IR (KBr):
(200 MHz, CDCl3):
n
1508, 1566, 1624, 3051, 3312 cmꢁ1. 1H NMR
d
7.19–7.26 (t, J¼7.0 Hz, 1H), 7.32–7.54 (m, 5H),
7.62–7.83 (m, 5H), 8.74–8.77 (d, J¼4.5 Hz, 1H). 13C NMR (50 MHz,
CDCl3):
d 110.12, 114.12, 118.00, 123.19, 127.04, 127.57 (2C), 127.98,
129.32 (3C), 135.61, 136.86, 139.24, 143.58, 147.86, 152.96. HRMS
(MþH)þ calcd for C17H14NO: 248.1075, found: 248.1028.
(KBr):
n
1166,1201,1605, 2837, 2938 cmꢁ1.1H NMR (200 MHz, DMSO-
4.4.2. (E)-4-(4-Methoxystyryl)quinolin-8-ol (4b)
d6): 2.36 (s, 3H), 3.82 (s, 3H), 3.89 (s, 6H), 6.31 (s, 2H), 7.36–7.64 (m,
d
4-(4-Methoxystyryl)-8-tosyloxyquinoline 3b (1.0 g, 2.32 mmol)
and NaOH (1 M, 11.6 mL, 11.6 mmol) were used to prepare the title
compound. The product was collected by filtration and recrystal-
6H), 7.79–7.82 (d, J¼7.9 Hz, 2H), 8.10–8.17 (m, 2H), 8.70–8.72 (d,
J¼4.9 Hz,1H).13C NMR (50 MHz, DMSO-d6):
d 21.96, 56.24, 56.83 (2C),
91.80, 107.04, 117.50, 122.20, 122.49, 124.00, 126.32, 127.61, 128.08,
129.19 (2C),130.64 (2C),133.28,142.30,145.28,146.00,146.20,151.50,
160.72 (3C), 162.42. HRMS (MþH)þ calcd for C27H26NO6S: 492.1481,
found: 492.1485.
lized from
powder (0.58 g, 91%). Mp: 172–173 ꢂC (lit.11 163–165 ꢂC); IR (KBr):
1250, 1570, 1605, 3022, 3326 cmꢁ1. 1H NMR (200 MHz, CDCl3):
3.8
a CHCl3/EtOH mixture to give a reddish brown
n
d
(s, 3H), 6.94–6.98 (d, J¼8.8 Hz, 2H), 7.18–7.28 (m, 2H), 7.49–7.71
(m, 6H), 8.71–8.74 (d, J¼4.4 Hz, 1H). 13C NMR (50 MHz, DMSO-d6):
4.3.7. (E)-4-(2-(Pyridin-4-yl)vinyl)-8-tosyloxyquinoline (3g)
4-Bromo-8-tosyloxyquinoline 2 (200 mg, 0.53 mmol), PdCl2
(2.82 mg, 0.016 mmol), PPh3 (8.35 mg, 0.03 mmol), K2CO3
(73.32 mg, 0.53 mmol) and 0.11 mL 4-vinylpyridine were the
d 56.06, 111.75, 114.67, 115.08 (2C), 117.43, 120.78, 127.44, 128.08,
129.87 (2C), 129.94, 135.50, 139.94, 143.46, 148.42, 154.31,
160.69. HRMS (MþH)þ calcd for C18H16NO2: 278.1181, found:
278.1176.